Bernard P. Schachtel, M.D.

Chief Scientific Officer & Founder

Dr. Schachtel graduated as valedictorian cum laude from the Collegiate School in New York City.  He received his undergraduate degree from Yale College and his MD from Columbia University, College of Physicians and Surgeons.  After pediatric residency at Yale and a research fellowship at the National Institutes of Health, he was a Robert Wood Johnson Clinical Scholar in the Departments of Medicine and Epidemiology and Public Health at the Yale University School of Medicine.  Except for a 5-year appointment as Adjunct Professor of Epidemiology and Biostatistics at McGill University, throughout his career Dr. Schachtel has held an academic appointment at Yale, where he is currently Lecturer in Epidemiology and Public Health.  His curriculum vitae lists over 300 original scientific presentations, peer-reviewed publications, and chapters in clinical pharmacology textbooks.  Dr. Schachtel has developed several new methods and models for studying symptoms associated with a variety of medical conditions, ranging from pain to heartburn to nausea.  He was described by Dr. Louis Lasagna, a founding father of clinical pharmacology, as “a specialist in the measurement of subjective endpoints, one of our most imaginative researchers.”  A former member of the Board of Directors of the American Society of Clinical Pharmacology and Therapeutics, Dr. Schachtel has also served as Consultant to the U.S. Food and Drug Administration.